Purpose: To compare clinical outcomes of wavefront-guided LASIK with and without aspheric compensation in myopic eyes.
Methods: In this observational, single-center study, 134 eyes were treated using an aspheric module in combination with wavefront-guided profiles (PTA-algorithm) and compared to 146 eyes treated with the predecessor wavefront-guided software (APT) that has no aspheric compensation. All treatment plans included the Rochester nomogram that accounts for the preoperative manifest refraction and interaction of higher order aberrations. Active eye-tracking (including cyclorotational movements) was utilized during photoablation.
Results: Results at the 3-month follow-up: 67 % of PTA-treated eyes and 39 % of APT-treated eyes achieved an uncorrected distance visual acuity (UDVA) of 20/20 or better. Change in mean higher order aberration root-mean-square (HOA RMS) after PTA treatments was not statistically significant (p = 0.18). The increase in HOA RMS after APT treatments was statistically significant (p = 0.003). Change in mean postop spherical aberration (SA) after PTA treatments was not statistically significant (p = 0.27). The change in SA after APT treatments was statistically significant (p = 0.001). In both cohorts, mean uncorrected low-contrast visual acuity was statistically not different to preoperative corrected values.
Conclusions: Adding an aspheric compensation to wavefront-guided myopic LASIK statistically improved clinical results in terms of visual acuity and refractive outcomes. Low-contrast visual acuity was not negatively affected in either group. While in APT-treated eyes mean HOA RMS and mean SA were significantly increased postoperatively, PTA-treated eyes showed neither induced HOA RMS nor induced SA.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00417-012-2143-0 | DOI Listing |
PLoS One
January 2025
Department of Ophthalmology, University of Washington, Seattle, WA, United States of America.
To investigate macula and optic nerve head (ONH) mitochondrial metabolic activity using flavoprotein fluorescence (FPF) in normal, glaucoma suspect (GS), and open-angle glaucoma (OAG) eyes we performed a cross-sectional, observational study of FPF in normal, GS, and OAG eyes. The macula and ONH of each eye was scanned and analyzed with a commercially available FPF measuring device (OcuMet Beacon, OcuSciences Inc., Ann Arbor, MI).
View Article and Find Full Text PDFJ Ophthalmic Inflamm Infect
January 2025
School of Medicine, National Taiwan University, Taipei, Taiwan.
Purpose: To identify the macular retinal layer thickness changes in polyarteritis nodosa (PAN) patients without pathological findings appearing in color fundus photography (CFP), and to investigate the correlations with disease durations.
Methods: A total of 24 PAN patients who had been for 3 years or more and underwent SD-OCT were recruited from the UK Biobank, with exclusions for diabetes, eye disease, or abnormal CFP findings. Only the right eyes were included, with each PAN patient paired one-to-one with a control matched for age, sex, and ethnicity.
Cornea
January 2025
Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Purpose: To describe a case series of patients with 12 fungal keratitis treated with caspofungin 0.5% eye drops.
Methods: In this study, 12 patients diagnosed with fungal keratitis were treated with topical compounded caspofungin 0.
Cornea
January 2025
Department of Ophthalmology, University of Cyprus Medical School, Nicosia, Cyprus.
Purpose: To assess the impact of autologous serum (AS) tears at a 50% concentration on the ocular surface of patients with refractory dry eye disease (DED) because of Sjogren syndrome.
Methods: Twenty eyes of ten patients with severe immune-mediated DED were contralaterally randomized to receive either AS tears 50% or artificial tears between June 2021 and May 2023. Changes in tear stability, ocular surface staining, and in the morphology of the corneal sub-basal nerves were evaluated before treatment and at 1, 2, and 3 months after treatment using objective tests for DED and confocal microscopy.
Cornea
January 2025
Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA.
Purpose: To report on optical coherence tomography angiography (OCTA) in patients with a type 1 Boston keratoprosthesis (KPro) and determine its feasibility through assessment of imaging artifacts.
Methods: KPro and non-KPro subjects were matched for age, gender, and glaucoma diagnosis. OCTA images of the peripapillary optic nerve were obtained, reviewed by 2 readers masked to the diagnosis for artifacts and usability, and used for microvascular measurements.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!